Galectin Therapeutics Reports 2016 Financial Results and Provides Business Update

Go back to Galectin Therapeutics Reports 2016 Financial Results and Provides Business Update
GALECTIN (NASDAQ: GALT) Delayed: 3.68 +0.11 (3.08%)
Previous Close $3.57    52 Week High $3.05 
Open $3.62    52 Week Low $0.49 
Day High $3.74    P/E N/A 
Day Low $3.59    EPS $-1.32 
Volume 174,898